Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study
scientific article
Author/s
author: Hagop Kantarjian, Naveen Garg, Alessandra Ferrajoli, William G Wierda, Susan O'Brien, Michael J. Keating, Susan Lerner, Jeffrey C. Jorgensen, Marylou Cardenas Turanzas, Julia Hoellenriegel, Xuelin Huang, Jan A Burger, Elena Hartmann, Nathalie Y Rosin, Gracy Zacharian, Andreas Rosenwald, Ghayathri Jeyakumar, Graciela M Nogueras-Gonzalez
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.